NOCTURNAL Trademark

Trademark Overview


On Thursday, December 16, 2021, a trademark application was filed for NOCTURNAL with the United States Patent and Trademark Office. The USPTO has given the NOCTURNAL trademark a serial number of 97175653. The federal status of this trademark filing is REGISTERED as of Tuesday, August 22, 2023. This trademark is owned by Nocturnal Product Development, LLC. The NOCTURNAL trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, and Computer & Software Services & Scientific Services categories with the following description:

business financial and funding consulting services, namely, providing information that advises companies and universities seeking to obtain grant funding from federal, state, and local governments for clinical research and clinical trials

business consulting services, namely, providing assistance in the development of innovation-driven business strategies and creative ideation; business consulting in the field of clinical trials, namely, assisting with clinical data and regulatory submission management on behalf of medical, biopharmaceutical, and biotechnology companies; business consulting services, namely, providing information to companies and universities on managing grant funding from federal, state, and local governments for clinical research and clinical trials; business consulting services, namely, maintaining design history files, performing business risk analysis, and planning and executing verification and validation activities that support clinical investigations in domestic and international settings, namely, providing independent review of clinical trials for business purposes, developing regulatory strategies for obtaining domestic and international approvals in the nature of clinical data and regulatory ...

product research and development in the fields of medical products and medical devices; mechanical engineering services for electronics packaging, structural finite element analysis, and thermal analysis; product design and development in the field of medical devices, namely, developing extensive analog circuitry, digital circuitry, embedded firmware, and application software to meet the demands of medical products and medical devices; product design and development in the field of medical devices, namely, electromagnetic compatibility (EMC) and electrical safety testing to meet the demands of international regulatory standards; product design and development in the field of medical products and medical devices, namely, development of laser systems, fiber and electro-optics, and biophotonics for spectroscopy and optical characterization of living tissue via both diffuse reflectance and fluorescence; cloud-based Platform as a Service (PaaS) featuring computer software platforms that com...
nocturnal

General Information


Serial Number97175653
Word MarkNOCTURNAL
Filing DateThursday, December 16, 2021
Status700 - REGISTERED
Status DateTuesday, August 22, 2023
Registration Number7141791
Registration DateTuesday, August 22, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 6, 2023

Trademark Statements


Goods and Servicesbusiness financial and funding consulting services, namely, providing information that advises companies and universities seeking to obtain grant funding from federal, state, and local governments for clinical research and clinical trials
Goods and Servicesbusiness consulting services, namely, providing assistance in the development of innovation-driven business strategies and creative ideation; business consulting in the field of clinical trials, namely, assisting with clinical data and regulatory submission management on behalf of medical, biopharmaceutical, and biotechnology companies; business consulting services, namely, providing information to companies and universities on managing grant funding from federal, state, and local governments for clinical research and clinical trials; business consulting services, namely, maintaining design history files, performing business risk analysis, and planning and executing verification and validation activities that support clinical investigations in domestic and international settings, namely, providing independent review of clinical trials for business purposes, developing regulatory strategies for obtaining domestic and international approvals in the nature of clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with applications for drug and medical device approval, and assisting businesses in preparing and filing applications for and managing government grant funding in the field of medical devices and products; business consulting services, namely, assisting with clinical trial submissions, namely, regulatory submission management, namely, assisting others in preparing and filing applications for new drugs and new medical devices with governmental regulatory bodies; business consulting services, namely, assisting in obtaining domestic and international approvals by developing regulatory strategies and authoring product approval and product registration submissions; business consulting services, namely, project management services to identify and mitigate potential risks in complex projects; business consulting services, namely, consultation in the fields of medical products and medical devices
Goods and Servicesproduct research and development in the fields of medical products and medical devices; mechanical engineering services for electronics packaging, structural finite element analysis, and thermal analysis; product design and development in the field of medical devices, namely, developing extensive analog circuitry, digital circuitry, embedded firmware, and application software to meet the demands of medical products and medical devices; product design and development in the field of medical devices, namely, electromagnetic compatibility (EMC) and electrical safety testing to meet the demands of international regulatory standards; product design and development in the field of medical products and medical devices, namely, development of laser systems, fiber and electro-optics, and biophotonics for spectroscopy and optical characterization of living tissue via both diffuse reflectance and fluorescence; cloud-based Platform as a Service (PaaS) featuring computer software platforms that communicate with and collect data from medical products and medical devices; product design and development in the field of medical products and medical devices, namely, developing extensive analog circuitry, digital circuitry, embedded firmware, and application software for use with medical products and medical devices including topical electronic medical devices, active electronic implants, implantable pacemakers, defibrillators, diagnostic catheters, ablation catheters, and neurostimulators; business product development consulting services, namely, providing assistance in the development of leading-edge technologies for medical, biopharmaceutical, and biotechnology companies

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, December 21, 2021
Primary Code035
First Use Anywhere DateSaturday, March 31, 2012
First Use In Commerce DateSaturday, March 31, 2012

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, November 23, 2022
Primary Code036
First Use Anywhere DateSaturday, March 31, 2012
First Use In Commerce DateSaturday, March 31, 2012

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 21, 2021
Primary Code042
First Use Anywhere DateMonday, February 28, 2011
First Use In Commerce DateMonday, February 28, 2011

Trademark Owner History


Party NameNocturnal Product Development, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressDurham, NC 27713

Party NameNocturnal Product Development, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDurham, NC 27713

Party NameNocturnal Product Development, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDurham, NC 27713

Trademark Events


Event DateEvent Description
Tuesday, August 22, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 22, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, June 6, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 6, 2023PUBLISHED FOR OPPOSITION
Wednesday, May 17, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 3, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 10, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 10, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 10, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 7, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 7, 2023NON-FINAL ACTION E-MAILED
Friday, April 7, 2023NON-FINAL ACTION WRITTEN
Tuesday, March 7, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 7, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 7, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 22, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 22, 2022NON-FINAL ACTION E-MAILED
Thursday, December 22, 2022NON-FINAL ACTION WRITTEN
Wednesday, November 23, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 22, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 22, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 26, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 26, 2022NON-FINAL ACTION E-MAILED
Monday, September 26, 2022NON-FINAL ACTION WRITTEN
Thursday, September 22, 2022ASSIGNED TO EXAMINER
Tuesday, December 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 20, 2021NEW APPLICATION ENTERED